Adidas AG shares slumped after the German shoemaker warned of an operating loss of as much as €700 million ($752 million) in 2023 from the fallout of its dispute with rapper and former partner Ye.
Posts published by “Tim Loh”
Bayer AG and Regeneron Pharmaceuticals Inc.’s blockbuster eye drug reached another clinical milestone by showing sustained efficacy in trials that could help the companies push back against a competing product from Roche Holding AG.
European regulators cleared Moderna Inc.’s Covid-19 shot for children aged 12 to 17, offering a second weapon in the push to vaccinate teenagers on the continent as the delta variant spreads.